[ET Net News Agency, 7 May 2025] HANSOH PHARMA (03692) fell 3.1% to HK$23.7.
It hits an intra-day low of HK$23.7, dipping below the 10-D SMA of HK$23.905, and an intra-day high of HK$24.75. The total shares traded was 4.52 million, with a value of HK$108.86m. The active buy/sell ratio is 63:37, with net buying turnover of HK$22.96m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$3.02m, with volume weighted average price of HK$23.975. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$5.34m, with volume weighted average price of HK$24.053.
The Hang Seng Index now rose 107 points, or 0.5% to 22,770.
Basic Information| Nominal | 23.700 | % Chg | -3.07% |
| High | 24.750 | Low | 23.700 |
| Shares Tr | 4.52m | Turnover | 108.86m |
| 10-D SMA | 23.905 | %H.V | 63.370 |
| 20-D SMA | 23.000 | VWAP | 24.066 |
| 50-D SMA | 21.258 | RSI14 | 56.828 |
Status: Dipping below the 10-D SMA, active buy/sell ratio is 63:37, with net buying turnover of HK$22.96m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 23.70 | -3.07 |
| SIHUAN PHARM (00460) | 0.73 | -1.35 |
| GRAND PHARMA (00512) | 6.75 | +12.69 |
| SINO BIOPHARM (01177) | 3.86 | -2.28 |
| LIVZON PHARMA (01513) | 26.15 | -0.57 |
| LUYE PHARMA (02186) | 2.04 | Unchanged |
| FOSUN PHARMA (02196) | 14.04 | +0.72 |
| SH PHARMA (02607) | 10.96 | +2.05 |
| CHINARES PHARMA (03320) | 4.98 | +0.40 |
| GOLDEN THROAT (06896) | 4.44 | +1.14 |
(ed)
